Nanomagnetic hydrogel based on chitosan, hyaluronic acid, and glucose oxidase as a nanotheranostic platform for simultaneous therapeutic and imaging applications

Theranostic platform including therapeutic agent and diagnostics factor is of great interest in the current cancer treatment research. In this study, we constructed a pH-responsive nanomagnetic hydrogel based on chitosan, hyaluronic acid, and glucose oxidase (NMH-CsHA-GOx) as a platform, which represents good performance both as a nanomedicine and as a dual-modal magnetic resonance imaging (MRI) contrast agent. The NMH-CsHA-GOx is a hybrid catalyst that catalyzes a cascade reaction that results in the production of hydroxyl radicals. This leads to the apoptosis and death of cancer cells under the mildly acidic TME. Moreover, the ultrasmall superparamagnetic Fe3O4 NPs act as the T1-weighted and T2-weighted (dual-modal) MRI contrast agents that can be used to identify the cancer cells. The r1 = 6.37, r2 = 27.07/mM/s, and r2/r1 ratio were obtained from MRI relaxivity measurements. The NMH-CsHA-GOx was characterized by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and vibrating sample magnetometry (VSM). The morphology of the hydrogel and nanomagnetic hydrogel were characterized by Field emission scanning electron microscopy (FESEM). The size and distribution of Fe3O4NPs were studied by Transmission electron microscopy (TEM) and X-ray elemental mapping, respectively. The analysis confirmed the very small size of the Fe3O4 NPs (5–12 nm), which were dispersed uniformly. The NMH-CsHA-GOx represents high selectivity between normal cells (L929 mouse fibroblast cell line) and tumor cells (MCF-7 breast cancer cell line). The pH-sensitive NMH-CsHA-GOx, can produce a controlled amount of hydroxyl radical under the mildly acidic TME.